日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054

更正:拮抗剂抗PD-L1单克隆抗体LY3300054的发现和临床前表征

Li, Yiwen; Carpenito, Carmine; Wang, George; Surguladze, David; Forest, Amelie; Malabunga, Maria; Murphy, Mary; Zhang, Yiwei; Sonyi, Andreas; Chin, Darin; Burtrum, Douglas; Inigo, Ivan; Pennello, Anthony; Shen, Leyi; Malherbe, Laurent; Chen, Xinlei; Hall, Gerald; Haidar, Jaafar N; Ludwig, Dale L; Novosiadly, Ruslan D; Kalos, Michael

Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054

拮抗性抗PD-L1单克隆抗体LY3300054的发现及临床前表征

Yiwen Li, Carmine Carpenito, George Wang, David Surguladze, Amelie Forest, Maria Malabunga, Mary Murphy, Yiwei Zhang, Andreas Sonyi, Darin Chin, Douglas Burtrum, Ivan Inigo, Anthony Pennello, Leyi Shen, Laurent Malherbe, Xinlei Chen, Gerald Hall, Jaafar N Haidar, Dale L Ludwig, Ruslan D Novosiadly, 

A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation

双功能抗体受体结构域融合蛋白,同时靶向 IGF-IR 和 VEGF 进行降解

Yang Shen, Lin Zeng, Ruslan Novosyadlyy, Amelie Forest, Aiping Zhu, Andrew Korytko, Haifan Zhang, Scott W Eastman, Michael Topper, Sagit Hindi, Nicole Covino, Kris Persaud, Yun Kang, Douglas Burtrum, David Surguladze, Marie Prewett, Sudhakar Chintharlapalli, Victor J Wroblewski, Juqun Shen, Paul Bal

A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth

针对干细胞因子受体(c-Kit)的人类单克隆抗体可阻断肿瘤细胞信号传导并抑制肿瘤生长

Maria B Lebron, Laura Brennan, Christopher B Damoci, Marie C Prewett, Marguerita O'Mahony, Inga J Duignan, Kelly M Credille, James T DeLigio, Marina Starodubtseva, Michael Amatulli, Yiwei Zhang, Kaben D Schwartz, Douglas Burtrum, Paul Balderes, Kris Persaud, David Surguladze, Nick Loizos, Keren Paz,

Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis

靶向胰岛素样生长因子I受体的抗体可通过抑制肿瘤增殖和血管生成,增强多发性骨髓瘤对化疗的抗肿瘤反应。

Wu, Kai-Da; Zhou, Li; Burtrum, Douglas; Ludwig, Dale L; Moore, Malcolm A S

Genetic modulation of T cell receptor gene segment usage during somatic recombination

体细胞重组过程中T细胞受体基因片段使用的遗传调控

Livak, F; Burtrum, D B; Rowen, L; Schatz, D G; Petrie, H T

T cell receptor (TCR)-beta gene recombination: dissociation from cell cycle regulation and developmental progression during T cell ontogeny

细胞受体(TCR)-β基因重组:与细胞周期调控和T细胞发育过程中的发育进程相分离

Tourigny, M R; Mazel, S; Burtrum, D B; Petrie, H T

Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death

bcl-2表达调控细胞分裂周期进程:抑制程序性细胞死亡的潜在机制

Mazel, S; Burtrum, D; Petrie, H T